2-171360492-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001321154.2(METTL8):āc.165G>Cā(p.Lys55Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000415 in 1,613,660 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001321154.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
METTL8 | NM_001321154.2 | c.165G>C | p.Lys55Asn | missense_variant | 3/10 | ENST00000375258.9 | NP_001308083.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
METTL8 | ENST00000375258.9 | c.165G>C | p.Lys55Asn | missense_variant | 3/10 | 5 | NM_001321154.2 | ENSP00000364407.4 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152108Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000558 AC: 14AN: 250978Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135644
GnomAD4 exome AF: 0.0000308 AC: 45AN: 1461434Hom.: 0 Cov.: 32 AF XY: 0.0000289 AC XY: 21AN XY: 727022
GnomAD4 genome AF: 0.000145 AC: 22AN: 152226Hom.: 1 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74426
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 09, 2022 | The c.165G>C (p.K55N) alteration is located in exon 3 (coding exon 2) of the METTL8 gene. This alteration results from a G to C substitution at nucleotide position 165, causing the lysine (K) at amino acid position 55 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at